Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network: Our Bureau, Mumbai Thursday, October 1, 2026, 13:30 Hrs [IST] Vytalyou, a doctor-led longevity a ...

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears: Châtillon, France Thursday, October 1, 2026, 18:00 Hrs [IST] DBV Technologies, a la ...

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa: Rahway, New Jersey Thursday, Octob ...

Acrotech Biopharma Inc., a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of Adquey (difamilast 1%) ointment, a ...

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...

Baby Memorial Hospital Vadakara enters Asia and India Book of Records on World Heart Day: Our Bureau, Mumbai Thursday, October 1, 2026, 14:50 Hrs [IST] Baby Memorial Hospital (BMH ...

Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea: Woburn, Massachusetts Thursday, October 1, 2026, 12:00 H ...

Boehringer Ingelheim announced that it projects its investments into sustainability-related programmes and health partnerships that aim to help improve the lives of people, animals and their ...

US FDA accepts Roche’s NDA for fenebrutinib in both relapsing and primary progressive multiple sclerosis: Basel Thursday, October 1, 2026, 09:00 Hrs [IST] Roche announced that t ...

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support: Our Bureau, Mumbai Thursday, October 1, 2026, 15:45 Hrs [IST] Truevis Technologies Pvt. Ltd., in ...

Hutchmed announces AstraZeneca submits NDA to US FDA for Orpathys plus Tagrisso in MET-driven EGFR-mutated lung cancer: Hong Kong, Shanghai Thursday, October 1, 2026, 14:00 Hrs [I ...